.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized evidence and international treatment recommendations continue to support methotrexate as a foundational conventional synthetic DMARD for many patients with newly diagnosed rheumatoid arthritis. Early treatment improves the likelihood of achieving low disease activity or remission and reduces the risk of progressive joint damage. For general physicians, the practical issue is not simply choosing methotrexate but implementing it safely: baseline blood counts, liver function, renal function, hepatitis screening where appropriate, folic-acid supplementation, pregnancy considerations and regular laboratory monitoring are all important. Treatment response should be assessed at defined intervals, and therapy escalated when the patient is not moving toward the target. Rheumatoid arthritis care also requires management of cardiovascular risk, vaccination and bone health. The modern treat-to-target model therefore turns methotrexate initiation into the first step of an adaptive pathway rather than a final decision. Prompt specialist referral is warranted when diagnosis is uncertain, extra-articular disease is present or disease activity remains high despite initial treatment.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized evidence and international treatment recommendations continue to support methotrexate as a foundational conventional synthetic DMARD for many patients with newly diagnosed rheumatoid arthritis. Early treatment improves the likelihood of achieving low disease activity or remission and reduces the risk of progressive joint damage. For general physicians, the practical issue is not simply choosing methotrexate but implementing it safely: baseline blood counts, liver function, renal function, hepatitis screening where appropriate, folic-acid supplementation, pregnancy considerations and regular laboratory monitoring are all important. Treatment response should be assessed at defined intervals, and therapy escalated when the patient is not moving toward the target. Rheumatoid arthritis care also requires management of cardiovascular risk, vaccination and bone health. The modern treat-to-target model therefore turns methotrexate initiation into the first step of an adaptive pathway rather than a final decision. Prompt specialist referral is warranted when diagnosis is uncertain, extra-articular disease is present or disease activity remains high despite initial treatment.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
